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Abstract 
 
We have previously reported that a universal growth law, as proposed by West and collaborators for 
all living organisms, appears to be able to describe also the growth of tumors in vivo. In contrast to 
the assumption of a fixed power exponent p (assumed by West et al. to be equal to 3/4), we show in 
2this paper the dynamic evolution of p from 2/3 to 1, using experimental data from the cancer 
literature and in analogy with results obtained by applying scaling laws to the study of 
fragmentation of solids. The dynamic behaviour of p is related to the evolution of the fractal 
topology of neoplastic vascular systems and might be applied for diagnostic purposes to mark the 
emergence of a functionally sufficient (or effective) neo-angiogenetic structure. 
 
1. Introduction 
 
In a previous paper we have reported that West et al.’s model (2001) of “universal growth” may 
also be extended to describe the growth dynamics of in vitro and in vivo (clinical) tumors (Guiot et 
al., 2003). The model assumes that the incoming rate of energy flow B (average resting metabolic 
energy) for a living organism is related to its mass m by a power law of the type pmB  , with p =
3/4. Such a value of the power exponent was firstly proposed by Kleiber (1932) and recently 
justified by West et al. (1997), who argued that the distribution network (i) branches to reach 
everywhere in any three-dimensional organism (according to a fractal distribution), (ii) has terminal 
units (e.g., capillaries or terminal xylem) independent of the body size, and (iii) minimizes the total 
resistance and hence the energy required to distribute nutrients. Also Banavar et al. (1999) 
approached the problem of defining the exponent for a general distributive system. They showed 
that B is expected to scale as MD/(1+D) if the efficiency of the vascular network is maximized, D 
being the dimensionality of the embedding space. Thus, in a three-dimensional space p=3/4 follows 
from the condition of most efficient space-filling, without having to recur to fractals.  
However, the “correct” value of the p exponent remains a controversial issue since other 
values have also been proposed in the literature. For instance, a recent paper (Dodds et al., 2001) 
shows that p=3/4 , which was the classical value considered in the pioneer paper by Kleiber (1932), 
does not always yield a significantly better fit for all available data than p=2/3, which is based on a 
simple geometrical scaling of the body surface area available for heat dissipation. Even the trivial 
3assumption p=1 has been justified, as the one leading to the simplest hypothesis of direct 
proportionality between incoming energy flow and mass of the organism.  
In our opinion the controversy reflects the rather ambigous formulation of the question. 
Nature is of course more complex than even the most sophisticated mathematical model. Changing 
the ingredients of the model affects the prediction of the p value and, in turn, may correspond to 
different phases in the growth of the organism (or tumor).  Thus the universality, as defined e.g. in 
the framework of a recently proposed ‘black box’ formalism by Hirsekorn and Delsanto (2004), 
would refer not to a single value of p, but to a suitable range of values. Here in this present 
contribution we suggest that p changes dynamically in the range 2/3 to 1, reflecting the different 
developmental stages of the vascular network and, more specifically, the development of 
angiogenesis.  Our conjecture is supported by the prediction of similar results by Carpinteri and 
Pugno (2002a) in a completely different context (see next Section) and by several instances of 
observation of evolution of the fractal cancer topology (Section 3). In Section 4 a mathematical 
model of growth dynamics with variable p is presented and some results are drawn and discussed in 
the Conclusions.  
 
2. Correlation between scaling laws and fractal cancer topology  
In a completely different context Carpinteri and Pugno (2002a) have developed universal scaling 
laws for energy dissipation during the fragmentation of solids, by assuming a self-similar (i.e., 
fractal) size distribution of fragments. Their assumption implies a power law such as DrN  ,
where N is the number of fragments with size larger than r, and D is the so-called fractal exponent 
(a real positive number) of the fragment size distribution. Accordingly they obtain by integration 
the total surface S of fragments, as a function of their total volume V, as 3DVS  , with 32 <<D .
4Likewise, if the biological clusters (fragments) distribution is fractal in nature, and the energy 
transportation (dissipation) is proportional to their surface, neglecting the variation of density 
during growth ( mV  ) yields the scaling law pmB  , with 3Dp = , with 13/2 << p , as 
conjectured in the Introduction.  
It is interesting to note that, according to the interpretation based on the analysis by Carpinteri 
and Pugno (2002a), the exponent p should be strongly related to the fractal nature of cancer 
topology and thus susceptible of independent measurements. The idea of a fractal topology has been 
proposed in the past by many researchers (see e.g. Baish and Jain, 2000), in particular Baish et al. 
(1996) have shown that in-vivo estimations of the fractal dimension of planar vascular networks 
based on the box-counting method, (see Bunde and Havlin, 1994) range between 1 and 2. Starting 
from the 2D observed exponent stereological methods give an estimate of the corresponding 3D 
value. From a practical point of view the result is close to the 2D fractal exponent plus one, i.e. D
would range between 2 and 3. Correspondingly, the value of 3Dp = is comprised between 2/3 
and 1. In particular, in normal tissues and in four different tumor lines, implanted in the dorsal 
skinfold chamber in immunodeficient mice, Baish et al. (1996) observed a value of 2 
(corresponding to D = 2+1=3 in three-dimension and p =1) for normal capillaries, 1.7 ( D =2.7, p
=0.9) for arteries and vein and 1.88 ( D =2.88, p =0.96) for tumor vessels, showing that tumor 
vasculatures are more chaotic and inefficient than normal capillaries, which are almost uniformely 
distributed. These observations are in agreement with our conjecture and, more specifically, with 
the prediction of a scaling exponent of 2 for the ‘space-filling’ growth model, 1.71 for the ‘diffusion 
limited aggregation’ model and 1.90 for the ‘invasion percolation’ model (Baish et al., 1996). Thus 
tumor vascularization does not fully satisfy the condition of a ‘space-filling network’, assumed by 
West et al. (1997), but could perhaps be better described by an ‘invasion percolation’ model. 
Accordingly, normal tissues and tumors differ deeply in their vascular structure and metabolism.  
 
53. Evolution of the fractal cancer topology  
 
We report here some instances of observed evolution of the fractal cancer topology. The first work, 
by Gazit et al. (1997) concerns the vascular system changes during growth of tumors implanted in 
mice. Both the fractal dimension D and the vessel density were monitored on two-dimensional 
images during normal development from the 6-th to the 12-th day, showing an increase from around 
1.6 ( D =2.6 in three-dimensions) to a maximum value of 1.73 ( D =2.73) on the 10-th day, followed 
by a decrease. Likewise also the vessel density shows a large increase, reaching its maximum on the 
11-th day, before it decreases. The authors were able to estimate a nearly linear increase in D of 
0.06 per day correlated to a nearly linear increase in vessel density of 138/cm2 per day.  
 
In another relevant paper the extraembryonic vascular network of the chick embryo was 
investigated by Vico et al (1998) with similar methods. They found that the vascular fractal 
dimension increases continuously from about 1.3 ( D =2.3) by the 60-th hour until about 1.68 
( D =2.68) by the 112-th hour, when a plateau is reached and D remains stable at the value of 
approximately 1.7 (D=2.7). Provided that the angiogenetic process is antagonized with angiostatic 
factors, the fractal dimensionality of the vascular network has been proven to reflect the observed 
decrease in branching patterns. 
 
Also Guidolin et al (2003) showed that, after delivering docetaxel to cultured HUVEC cells in 
Matrigel, the fractal dimension decreases of about 10% from the starting value of 1.20 ( D =2.20). 
Finally, the already cited paper by Parsons-Wingerter et al. (1998) shows similar effects after 
angiostatin delivering in the quail chorioallontoic membrane. 
 
64. A mathematical model  
According to the ontogenetic growth model of West et al. (2001) and its extension to neoplastic 
growths by Guiot et al (2003), the actual mass m of the tumor and its rate of growth, dm/dt, are non-
linearly related: 
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where M is the asymptotic value of m(t) and a is a parameter related to the metabolic rate of the 
particular tumor cell line considered. We have removed the assumption of p=3/4 replacing it 
with ( )1,32p , as conjectured in the Introduction. An unspecified value of p has also been 
assumed in a paper by Delsanto et al (2004), in which the ontogenetic growth model is tested under 
controlled conditions of malnourishment and applied mechanical stress. From Eq (1) the universal 
growth law follows: 
 
Pe1 =r , with ( ) pMmr = 1/ and ( ) ( )01ln1P rbtp = , (2) 
 
where ( )00 == tmm , ( ) pMmr = 100 and  
 1= pMab (3) 
 
For p=3/4 the growth predicted by Eq. (2) coincides with the West et al.’s model (Guiot et al., 
2003). 
Using Eq. (1) it can be shown that m(t) exhibits an inflection point at t=t’, corresponding to 
m=m’, which depends on the value of p. The simplest way to determine m’ is to plot the 
7experimental values of m and dm/dt in a cartesian plane with m as abscissa and dm/dt as ordinate. 
The curve dm/dt vs. m reaches a maximum at m=m’, which can be accurately identified. By 
assuming a dynamic evolution of the fractal exponent p=p(t), but with a slow rate of change (i.e. 
neglecting  dp/dt in the derivatives) it follows that: 
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From the plot dµ/dt vs. µ we obtain the best fitting values of b and of the exponent p corresponding 
to the mass m’ (and time t’).  Then M and a can be immediately computed from Eqs. (5) and (3), 
respectively. At this point p can be evaluated in its dynamical evolution (i.e. for each value of m and 
t) by mean of Eq. (4). 
As a first example of application of the procedure, we consider the analysis reported by 
Torres et al. (1995) in which a model for the investigation of angiogenesis is presented. It consists 
in the implantation of a Lewis’s lung carcinoma multicellular tumor spheroid into the dorsal 
skinfold chamber of mice. The authors monitored both the morphometric parameters of tumor 
growth and the development of the vascular networks around the tumor focus, using intravital 
microscopy. By applying our procedure to their data we obtain the results reported in Figure 1. 
After an initial decrease, p starts to grow up to a value around 3/4 when the angiogenetic process is 
apparently completed. According to Parsons-Wingerter et al. (1998) and Vico et al. (1998), p is 
expected to grow with the vascular density. However, from our plot it appears that p starts growing 
8only when the vascular density has already reached a considerable level. Unfortunately, the latter 
authors do not consider the evolution from its very beginning, yet they also show some delay in the 
relationship between fractal dimension and vascular density. We may infer that the initial decrease 
of p is due to the transition from the original (optimal) network to the subsequent pre-angiogenetic 
structure. A new vascular network needs to be well established before inducing a growth in p.
As a second example (Fig. 2) we investigate three out of five cell lines of tumors growing in 
mice, as reported by Steel (1977). The data from the other two cell lines cannot be used for this 
procedure since the short duration of the corresponding experimental series does not allow a proper 
estimate of the tumor mass at the inflection point. Note that, regardless of the cancer type, the 
power exponent p is observed to change dynamically, i.e., after an initial decrease (related to the 
implantation process as previously discussed), it eventually rises up to saturation.  
 
5. Discussion and concluding remarks 
 
In this paper we have studied the correlation between tumor topology and the scaling exponent p,
which we have conjectured to vary dynamically in the range (2/3,1). Consequently, we have 
modified the ontogenetic growth model of West et al. (2001) and its extension to neoplastic growths 
by Guiot et al (2003), in order to develop a model for the prediction of the dynamic behaviour of p
.For the application of the model to the analysis of experimental data (tumor masses m) we have 
considered the plot of dm/dt vs. m, which allows in the simplest way to evaluate p. We found that, 
in general, after an initial decrease due to the ‘adaptation’ of the implanted tumor to the new 
environment in the avascular phase, p starts increasing. We conjecture that this point marks the 
switch in the dominant nutrient-replenishment mechanism, from passive diffusion to active 
perfusion conferred by a then functionally sufficient level of angiogenesis. This transition occurs in 
the three cell lines investigated by Steel (1997) at an average tumor diameter of 6.6 mm (±1.6
STD), clearly beyond the threshold of 2-3 mm which, according to Folkman (1971), should prompt 
9the onset of angiogenesis. Values of p beyond 0.75 may suggest that active perfusion is 
complemented by other supply mechanisms, such as passive diffusion, when vascular density 
approaches its plateau. For the data analyzed here, this dynamic p-behaviour appears to be 
independent of the in vivo cancer type. It is also interesting to note that the time at which p starts 
growing (supposedly following the onset of angiogenesis, i.e., after the neovascular network already 
improves distribution efficiency) ranges between 5.3 and 14.2 days after implantation of the tumor. 
After rescaling to the dimensionless time P defined in Eq. 2, this temporal interval falls into a much 
narrower range (from about 0.21 to 0.39). This P range might be further reduced with a proper 
analysis of the implantation mechanism. 
Based on the presented results, we argue that the scaling exponent p shows distinct dynamic 
patterns in vivo and that a monitoring of p may be of interest for diagnostic or therapeutic purposes 
if the correspondence of the minimum of p with the emergence of a functionally sufficient 
neoangiogenetic structure is confirmed. More specific experiments, including measurements of 
tumor volume and vascular density and fractality would be desirable, given the important 
implications of our assumptions for cancer research. 
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Figure Caption 
 
Figure 1. Prediction according to our model of the scaling exponent p vs. time, based on data from 
Torres et al. (1995) referring to tumors implanted in CB6 mice. The corresponding values 
of the vascular density are also reported. 
 
Figure 2. Prediction according to our model of the scaling exponent p vs. time, based on data from 
Steel (1977) referring to three different tumor cell lines implanted in mice. 
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